Categories: Health CareLatest

Lung complications of long COVID persist among people, says pulmonologist, Dr. Manisha Mendiratta

Faridabad, September 23, 2023:  Although the pandemic has passed, doctors in Delhi-NCR are seeing a range of post-acute respiratory complications in Covid-19 patients. According to Dr. Manisha Mendiratta, HOD & Senior Consultant – Pulmonology, with the 450-bedded Sarvodaya Hospital, Sector-8, Faridabad Many individuals continue to suffer from persistent shortness of breath and cough, even months after their initial infection. Others have developed conditions like pulmonary fibrosis, a progressive and debilitating disease. Many cases of bronchiectasis are also coming to light, where the airways become damaged and widened. These Lung-related complications necessitate long-term monitoring and management.

Speaking ahead of the World Lung day, Dr. Manisha Mendiratta, said: “In our practice, we are witnessing a range of post-acute respiratory sequelae in COVID-19 patients. There is a surge in the incidence of various lung problems and pulmonary complications due to long COVID. Before the pandemic, such cases were relatively rare. Now, we are seeing a substantial uptick in patients with lingering respiratory issues.”

She added: “Long COVID can manifest with various pulmonary complications. Patients may experience ongoing shortness of breath, persistent cough, or chest discomfort. Additionally, conditions like post-acute sequelae of SARS-CoV-2 infection (PASC) can lead to interstitial lung abnormalities, pulmonary fibrosis, or bronchiectasis. These complications can significantly impact a patient’s quality of life and require ongoing medical management.”

Dr. Manisha Mendiratta said that coronavirus can damage the lungs in many ways. “In mild cases of COVID-19, there can still be long-term or permanent damage to the lungs. Even when symptoms are not severe, the virus can cause inflammation in the airways and lung tissue. This can lead to scarring or fibrosis, reducing lung function and causing persistent breathing difficulties. Some individuals may experience chronic coughing, shortness of breath, or a decreased ability to exercise. While the extent of damage varies from person to person, it is essential to monitor lung health and seek medical attention if any respiratory symptoms persist,” she added.

While there is ongoing research and clinical trials to better understand and treat long-COVID pulmonary complications, there is no definitive medical solution at this time, according to the doctor. Patients often require a multi-disciplinary approach, including pulmonary rehabilitation, medications to manage symptoms, and lifestyle modifications. “Prognosis varies depending on the severity of complications, but some patients may need to manage these issues for an extended period or even lifelong. Ongoing research is essential to improve our understanding and develop more effective treatments for long-COVID pulmonary complications,” said Dr. Manisha Mendiratta.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago